Skip to main content
Addgene

pMSCV_FLT3
(Plasmid #223566)

Print

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 223566 Standard format: Plasmid sent in bacteria as agar stab 1 $85
Add to Cart

Backbone

  • Vector backbone
    pMSCV
  • Vector type
    Mammalian Expression, Retroviral
  • Selectable markers
    Puromycin

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    NEB Stable
  • Copy number
    Unknown

Gene/Insert

  • Gene/Insert name
    FLT3 wild type
  • Alt name
    FLT3
  • Species
    H. sapiens (human)
  • Insert Size (bp)
    2982
  • Entrez Gene
    FLT3 (a.k.a. CD135, FLK-2, FLK2, STK1)

Cloning Information

Resource Information

  • A portion of this plasmid was derived from a plasmid made by
    After purchasing Addgene plasmid #74498 (deposited by Lars Rönnstrand), proceeded with mutation and cloning.

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pMSCV_FLT3 was a gift from Hyun Woo Park (Addgene plasmid # 223566 ; http://n2t.net/addgene:223566 ; RRID:Addgene_223566)

  • For your References section:

    Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia. Shin JE, Kim SH, Kong M, Kim HR, Yoon S, Kee KM, Kim JA, Kim DH, Park SY, Park JH, Kim H, No KT, Lee HW, Gee HY, Hong S, Guan KL, Roe JS, Lee H, Kim DW, Park HW. Mol Cancer. 2023 Nov 6;22(1):177. doi: 10.1186/s12943-023-01837-4. 10.1186/s12943-023-01837-4 PubMed 37932786
Related items: